Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
Mason
R P
RP
Department of Biochemistry and Medicine, MCP Hahnemann University School of Medicine, Pittsburgh, Pennsylvania, USA.
Mason
P E
PE
D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017275:Isradipine / Q000009:adverse effects; D012307:Risk Factors
D002121:Calcium Channel Blockers; D017275:Isradipine